Your session is about to expire
← Back to Search
N/A
Treatment for Atrial Fibrillation (RAFT-AF Extend Trial)
N/A
Recruiting
Research Sponsored by Anthony Tang
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
All patients previously enrolled and randomized in the RAFT-AF Study that are eligible to enroll
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
Summary
This is an extended follow up study of the original RAFT-AF Study. The RAFT-AF study was a multi-centre randomized controlled trial with a prospective randomized open blinded endpoint trial (PROBE) design. Patients were randomized to either catheter ablation-based rhythm control of AF as compared to rate control of AF
Eligible Conditions
- Atrial Fibrillation
- Heart Failure
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Composite of mortality and Heart Failure Events
Secondary outcome measures
Heart Failure Events
all-cause mortality
Find a Location
Who is running the clinical trial?
Anthony TangLead Sponsor
2 Previous Clinical Trials
2,500 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger